These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3454763)

  • 1. Monoclonal antibodies to uveal melanoma.
    Damato BE; Campbell AM; McGuire BJ; Lee WR; Foulds WS
    Eye (Lond); 1987; 1 ( Pt 6)():686-90. PubMed ID: 3454763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies to human primary uveal melanomas demonstrate tumor heterogeneity.
    Damato BE; Campbell AM; McGuire BJ; Lee WR; Foulds WS
    Invest Ophthalmol Vis Sci; 1986 Sep; 27(9):1362-7. PubMed ID: 3744725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of surface antigens in uveal melanoma using monoclonal antibodies].
    Cernák A; Kalafut F; Kusenda J; Novotná L
    Cesk Oftalmol; 1989 May; 45(3):145-52. PubMed ID: 2743434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell surface antigens of human uveal melanoma identified by monoclonal antibodies.
    Kalafut F; Kusenda J; Novotná L; Cernák A
    Czech Med; 1988; 11(2):73-80. PubMed ID: 3137006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monoclonal antibodies and uveal melanomas].
    Le Rebeller MJ; Safi N; Larson S; Beba R; Kantor R; Donoso L
    Ophtalmologie; 1989; 3(3):180-2. PubMed ID: 2641105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane-bound regulators of complement activation in uveal melanomas. CD46, CD55, and CD59 in uveal melanomas.
    Goslings WR; Blom DJ; de Waard-Siebinga I; van Beelen E; Claas FH; Jager MJ; Gorter A
    Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1884-91. PubMed ID: 8759358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface antigenic profile of uveal melanoma lesions analysed with a panel of monoclonal antibodies directed against cutaneous melanoma.
    Carrel S; Schreyer M; Gross N; Zografos L
    Anticancer Res; 1990; 10(1):81-9. PubMed ID: 1692197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating melanoma-associated antigens in ocular melanoma.
    Whitmore WG; Witkin SS; Ellsworth RM
    Ann Ophthalmol; 1988 Jun; 20(6):212-7. PubMed ID: 3408088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A preliminary report on monoclonal antibodies against human uveal melanoma.
    Kalafut F; Kusenda J; Novotná L; Cernák A
    Neoplasma; 1987; 34(6):693-701. PubMed ID: 3431609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uveal melanoma: no expression of HLA-G.
    Hurks HM; Valter MM; Wilson L; Hilgert I; van den Elsen PJ; Jager MJ
    Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3081-4. PubMed ID: 11726606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the antigenic profile of uveal melanoma lesions with anti-cutaneous melanoma-associated antigen and anti-HLA monoclonal antibodies.
    Natali PG; Bigotti A; Nicotra MR; Nardi RM; Delovu A; Segatto O; Ferrone S
    Cancer Res; 1989 Mar; 49(5):1269-74. PubMed ID: 2917356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies to human melanoma-associated antigens: an amplified enzyme-linked immunosorbent assay for the detection of antigen, antibody, and immune complexes.
    Morgan AC; McIntyre RF
    Cancer Res; 1983 Jul; 43(7):3155-9. PubMed ID: 6850625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human monoclonal antibodies directed against melanoma tumor-associated antigens.
    Kan-Mitchell J; Imam A; Kempf RA; Taylor CR; Mitchell MS
    Cancer Res; 1986 May; 46(5):2490-6. PubMed ID: 3697990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic uveal melanoma: an ocular melanoma associated antigen in the serum of patients with metastatic disease.
    Donoso LA; Felberg NT; Edelberg K; Borlinghaus P; Herlyn M
    J Immunoassay; 1986; 7(4):273-83. PubMed ID: 3805289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A method to generate antigen-specific mAb capable of staining formalin-fixed, paraffin-embedded tissue sections.
    Wang X; Campoli M; Cho HS; Ogino T; Bandoh N; Shen J; Hur SY; Kageshita T; Ferrone S
    J Immunol Methods; 2005 Apr; 299(1-2):139-51. PubMed ID: 15896802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanoma inhibitory activity: a novel serum marker for uveal melanoma.
    Schaller UC; Bosserhoff AK; Neubauer AS; Buettner R; Kampik A; Mueller AJ
    Melanoma Res; 2002 Dec; 12(6):593-9. PubMed ID: 12459649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of human IgG, IgA, and IgM anti-melanoma monoclonal antibodies utilizing lymphocytes of an actively immunized melanoma patient.
    Abdel-wahab ZA; Gillanders WE; Darrow TL; Seigler HF
    Hum Antibodies Hybridomas; 1992 Jan; 3(1):32-9. PubMed ID: 1576321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An antimelanoma monoclonal antibody and the histopathology of uveal melanomas.
    Folberg R; Donoso LA; Atkinson BF; Ernst CS; Herlyn M; Arbizo VV
    Arch Ophthalmol; 1985 Feb; 103(2):275-9. PubMed ID: 2579631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous expression of melanoma-associated antigens in uveal melanomas.
    van der Pol JP; Jager MJ; de Wolff-Rouendaal D; Ringens PJ; Vennegoor C; Ruiter DJ
    Curr Eye Res; 1987 Jun; 6(6):757-65. PubMed ID: 3608565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic and cellular heterogeneity of primary uveal melanomas.
    Folberg R
    Arch Ophthalmol; 1986 Jun; 104(6):795, 798-9. PubMed ID: 3487304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.